Apr 15 |
UPDATE 4-Novavax investor Shah Capital pushes for board shakeup
|
Apr 13 |
Better Buy: Bluebird Bio Vs. Novavax
|
Apr 12 |
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
|
Apr 11 |
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
|
Apr 9 |
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
|
Apr 3 |
Ex-Pharma Executive and Cousin Admit to Insider Trading of Kodak
|
Apr 3 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Apr 2 |
1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague
|
Apr 1 |
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
|
Mar 29 |
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
|